SCShu‐Kong Chen

Shu‐Kong Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shu‐Kong Chen has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Daniel Yang‐Chih Shih

    Bureau of Food and Drug Analysis, Department of Health, Taipei, Taiwan

    1 shared publication
  • I‐Jen Wang

    Department of Pediatrics, Taipei Hospital, Department of Health, Taipei, Taiwan

    1 shared publication
  • Tien‐Jen Lin

    Wanfang Hospital and Graduate Institute of Injury Prevention and Control, Taipei Medical University, Taipei, Taiwan

    1 shared publication
  • Wei‐Chih Cheng

    Bureau of Food and Drug Analysis, Department of Health, Taipei, Taiwan

    1 shared publication
  • Ya‐Min Kao

    Bureau of Food and Drug Analysis, Department of Health, Taipei, Taiwan

    1 shared publication

Latest Publications

  • Determination of urine melamine by validated isotopic ultra‐performance liquid chromatography/tandem mass spectrometry

    by Wei‐Chih Cheng, Shu‐Kong Chen, Tien‐Jen Lin, I‐Jen Wang, Ya‐Min Kao, Daniel Yang‐Chih Shih

    Little is known about melamine (MEL) analysis in children's urine. In this study, an isotopic ultra‐performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) method was developed and systematically validated for the analysis of MEL in urine. The method is easily performed and comprises acidification, solid‐phase extraction (SPE) and UPLC/MS/MS analysis. 13 C 3 N 3 ( 15 NH 2 ) 3 was used as the internal standard (IS) for calibration. Transition ions m/z 127 > 85 of MEL and m/z 133 > 89 of the IS were used for quantification and m/z 127 > 68 of MEL was used for quantitative confirmation. Recovery and precision were assessed to guarantee the applicability of the method. The limit of quantification (LOQ) was 0.01 µg/mL while the calculated method detection limit was 0.006 µg/mL. The mean recoveries ranged from 96–99%. The method was then applied to analyze urine samples from children who had potentially consumed MEL‐tainted dairy products during screening in Taiwan. Ten nephrolithiasis cases and 20 age‐ and gender‐matched controls were selected for this study. Three out of the 10 nephrolithiasis cases had elevated levels of MEL. Comparatively, twenty age‐ and gender‐matched non‐nephrolithiasis controls consuming Taiwan brand milk powder all showed MEL levels lower than the detection limit except for two children with background levels of 0.02 µg/mL. The background level in these children urine samples was established by UPLC/MS/MS analysis. Positive results of urine MEL tests might be associated with nephrolithiasis in these candidates. Measurement of urine MEL concentration can be helpful in confirming MEL‐related nephrolithiasis, but its clinical application needs further clarification. Copyright © 2009 John Wiley & Sons, Ltd.